What shapes an injection decision
Peptide names what a substance is made of
A peptide is small, with joined parts forming a short string. Those same kinds of parts also make up proteins. Insulin is an example. A
Calling a product a peptide gives no answer about its safety or whether drug rules allow it. This explanation was checked on September 26, 2026. A
Talk through the injection plan
Ask for the ingredient and the product name
At the September 26, 2026 check, semaglutide was the ingredient used in Ozempic and in Wegovy. At that same check, Mounjaro and Zepbound used the ingredient tirzepatide. B
Approval from the Food and Drug Administration, or FDA, follows its review of one named product for a stated use. A
At the September 26, 2026 check, some of these products had approval for adults with type 2 diabetes to help control their blood sugar. Other products were approved for weight loss in people who meet the rules on that product's label. The labels put these uses alongside food and activity changes. B
For weight treatment, ask the clinician to check the label's rules for your age, weight and health problems. Ask which rule applies to you and why.
What is the ingredient called? What is the product called? What condition is the plan meant to treat? Keep those answers together. A familiar ingredient name alone leaves the product question open.
What shapes an injection decision
Made to order means compounded
To compound a drug is to make or mix medicine to meet a patient's needs in place of a ready-made product. A
Compounded drugs lacked FDA approval at the September 26, 2026 check. Before these drugs reach the market, the FDA does not assess their quality, safety or how well they work. A
What need of mine would a ready-made medicine leave unmet?
Talk through the injection plan
A research label is a different matter
Washington's Pharmacy Commission rules out 'research use only' ingredients in medicines made to order for patients. It also rules out ingredients marked 'not for human consumption'. Those words mean the ingredient is labelled for study, not for use in people. C
The commission sent this reminder in July 2026. It was still the state guidance at the September 30, 2026 check. C
Does the offer mention research use rather than patient care? Take that wording into the conversation. Ask for an explanation of the product itself and the rules that apply to it.